CVRx EPS - Earnings per Share 2021-2025 | CVRX
CVRx eps - earnings per share from 2021 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| CVRx Annual EPS |
| 2024 |
$-2.65 |
| 2023 |
$-1.99 |
| 2022 |
$-2.02 |
| 2021 |
$-4.16 |
| 2020 |
$-37.01 |
| CVRx Quarterly EPS |
| 2025-06-30 |
$-0.57 |
| 2025-03-31 |
$-0.53 |
| 2024-12-31 |
$-0.39 |
| 2024-09-30 |
$-0.57 |
| 2024-06-30 |
$-0.65 |
| 2024-03-31 |
$-1.04 |
| 2023-12-31 |
$-0.45 |
| 2023-09-30 |
$-0.43 |
| 2023-06-30 |
$-0.56 |
| 2023-03-31 |
$-0.55 |
| 2022-12-31 |
$-0.51 |
| 2022-09-30 |
$-0.48 |
| 2022-06-30 |
$-0.54 |
| 2022-03-31 |
$-0.49 |
| 2021-12-31 |
$68.54 |
| 2021-09-30 |
$-0.30 |
| 2021-06-30 |
$-48.48 |
| 2021-03-31 |
$-23.92 |
| 2020-12-31 |
$0.00 |
| 2020-09-30 |
$-9.56 |
| 2020-06-30 |
$-10.18 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$0.205B |
$0.051B |
|
CVRx Inc. is a commercial-stage medical device company. It focused on developing, manufacturing and commercializing neuromodulation solutions for patients with cardiovascular diseases. CVRx Inc. is headquartered in Minneapolis, MN.
|
